|
1
|
Yui MA and Rothenberg EV: Developmental
gene networks: A triathlon on the course to T cell identity. Nat
Rev Immunol. 14:529–545. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gómez-del Arco P, Kashiwagi M, Jackson AF,
Naito T, Zhang J, Liu F, Kee B, Vooijs M, Radtke F, Redondo JM and
Georgopoulos K: Alternative promoter usage at the Notch1 locus
supports ligand-independent signaling in T cell development and
leukemogenesis. Immunity. 33:685–698. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McCormack MP, Shields BJ, Jackson JT, Nasa
C, Shi W, Slater NJ, Tremblay CS, Rabbitts TH and Curtis DJ:
Requirement for Lyl1 in a model of Lmo2-driven early T-cell
precursor ALL. Blood. 122:2093–2103. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kelley CM, Ikeda T, Koipally J, Avitahl N,
Wu L, Georgopoulos K and Morgan BA: Helios, a novel dimerization
partner of Ikaros expressed in the earliest hematopoietic
progenitors. Curr Biol. 8:508–515. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HJ, Barnitz RA, Kreslavsky T, Brown
FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TA,
Chan S, et al: Stable inhibitory activity of regulatory T cells
requires the transcription factor Helios. Science. 350:334–339.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao S, Liu W, Li Y, Liu P, Li S, Dou D,
Wang Y, Yang R, Xiang R and Liu F: Alternative splice variants
modulates dominant-negative function of Helios in T-Cell leukemia.
PLoS One. 11:e01633282016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fontenot JD, Rasmussen JP, Gavin MA and
Rudensky AY: A function for interleukin 2 in Foxp3-expressing
regulatory T cells. Nat Immunol. 6:1142–1151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hill JA, Feuerer M, Tash K, Haxhinasto S,
Perez J, Melamed R, Mathis D and Benoist C: Foxp3
transcription-factor-dependent and -independent regulation of the
regulatory T cell transcriptional signature. Immunity. 27:786–800.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Getnet D, Grosso JF, Goldberg MV, Harris
TJ, Yen HR, Bruno TC, Durham NM, Hipkiss EL, Pyle KJ, Wada S, et
al: A role for the transcription factor Helios in human
CD4(+)CD25(+) regulatory T cells. Mol Immunol. 47:1595–1600. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sridharan R and Smale ST: Predominant
interaction of both Ikaros and Helios with the NuRD complex in
immature thymocytes. J Biol Chem. 282:30227–30238. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asanuma S, Yamagishi M, Kawanami K, Nakano
K, Sato-Otsubo A, Muto S, Sanada M, Yamochi T, Kobayashi S,
Utsunomiya A, et al: Adult T-cell leukemia cells are characterized
by abnormalities of Helios expression that promote T cell growth.
Cancer Sci. 104:1097–1106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakase K, Ishimaru F, Fujii K, Tabayashi
T, Kozuka T, Sezaki N, Matsuo Y and Harada M: Overexpression of
novel short isoforms of Helios in a patient with T-cell acute
lymphoblastic leukemia. Exp Hematol. 30:313–317. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujii K, Ishimaru F, Nakase K, Tabayashi
T, Kozuka T, Naoki K, Miyahara M, Toki H, Kitajima K, Harada M and
Tanimoto M: Over-expression of short isoforms of Helios in patients
with adult T-cell leukaemia/lymphoma. Br J Haematol. 120:986–989.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tabayashi T, Ishimaru F, Takata M, Kataoka
I, Nakase K, Kozuka T and Tanimoto M: Characterization of the short
isoform of Helios overexpressed in patients with T-cell
malignancies. Cancer Sci. 98:182–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joshi I, Yoshida T, Jena N, Qi X, Zhang J,
Van Etten RA and Georgopoulos K: Loss of Ikaros DNA-binding
function confers integrin-dependent survival on pre-B cells and
progression to acute lymphoblastic leukemia. Nat Immunol.
15:294–304. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saki N, Abroun S, Soleimani M, Mortazavi
Y, Kaviani S and Arefian E: The roles of miR-146a in the
differentiation of Jurkat T-lymphoblasts. Hematology. 19:141–147.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thornton AM, Korty PE, Tran DQ, Wohlfert
EA, Murray PE, Belkaid Y and Shevach EM: Expression of Helios, an
Ikaros transcription factor family member, differentiates
thymic-derived from peripherally induced Foxp3+ T regulatory cells.
J Immunol. 184:3433–3441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitchell JL, Seng A and Yankee TM: Ikaros,
Helios, and Aiolos protein levels increase in human thymocytes
after β selection. Immunol Res. 64:565–575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kollmann K, Heller G, Ott RG, Scheicher R,
Zebedin-Brandl E, Schneckenleithner C, Simma O, Warsch W, Eckelhart
E, Hoelbl A, et al: c-JUN promotes BCR-ABL-induced lymphoid
leukemia by inhibiting methylation of the 5′ region of Cdk6. Blood.
117:4065–4075. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parikh C, Subrahmanyam R and Ren R:
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic
potentials in mice. Cancer Res. 67:7139–7146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brambillasca F, Mosna G, Ballabio E,
Biondi A, Boulukos KE and Privitera E: Promoter analysis of TFPT
(FB1), a molecular partner of TCF3 (E2A) in childhood acute
lymphoblastic leukemia. Biochem Biophys Res Commun. 288:1250–1257.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mira E, León B, Barber DF, Jiménez-Baranda
S, Goya I, Almonacid L, Márquez G, Zaballos A, Martínez-A C, Stein
JV, et al: Statins induce regulatory T cell recruitment via a CCL1
dependent pathway. J Immunol. 181:3524–3534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoelzinger DB, Smith SE, Mirza N,
Dominguez AL, Manrique SZ and Lustgarten J: Blockade of CCL1
inhibits T regulatory cell suppressive function enhancing tumor
immunity without affecting T effector responses. J Immunol.
184:6833–6842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li CX, Ling CC, Shao Y, Xu A, Li XC, Ng
KT, Liu XB, Ma YY, Qi X, Liu H, et al: CXCL10/CXCR3 signaling
mobilized-regulatory T cells promote liver tumor recurrence after
transplantation. J Hepatol. 65:944–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan PY, Silva Carrera EA, De Kouchkovsky
D, Joannas LD, Hao L, Hu D, Huntsman S, Eng C, Licona-Limón P,
Weinstein JS, et al: The TAM family receptor tyrosine kinase TYRO3
is a negative regulator of type 2 immunity. Science. 352:99–103.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chauhan AK, Moore TL, Bi Y and Chen C:
FcγRIIIa-Syk Co-signal modulates CD4+ T-cell response and
Up-regulates Toll-like Receptor (TLR) expression. J Biol Chem.
291:1368–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beer PA, Knapp DJ, Miller PH, Kannan N,
Sloma I, Heel K, Babovic S, Bulaeva E, Rabu G, Terry J, et al:
Disruption of IKAROS activity in primitive chronic-phase CML cells
mimics myeloid disease progression. Blood. 125:504–515. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mullighan CG, Miller CB, Radtke I,
Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui
CH, et al: BCR-ABL1 lymphoblastic leukaemia is characterized by the
deletion of Ikaros. Nature. 453:110–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Winandy S, Wu P and Georgopoulos K: A
dominant mutation in the Ikaros gene leads to rapid development of
leukemia and lymphoma. Cell. 83:289–299. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Swindle CS, Bates JT, Ko R, Cotta
CV and Klug CA: Expression of a non-DNA-binding isoform of Helios
induces T-cell lymphoma in mice. Blood. 109:2190–2197. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai Q, Dierich A, Oulad-Abdelghani M, Chan
S and Kastner P: Helios deficiency has minimal impact on T cell
development and function. J Immunol. 183:2303–2311. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim J, Sif S, Jones B, Jackson A, Koipally
J, Heller E, Winandy S, Viel A, Sawyer A, Ikeda T, et al: Ikaros
DNA-binding proteins direct formation of chromatin remodeling
complexes in lymphocytes. Immunity. 10:345–355. 1999. View Article : Google Scholar : PubMed/NCBI
|
